...
首页> 外文期刊>Diabetes care >Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial
【24h】

Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial

机译:生活方式干预计划与能量限制的地中海饮食的影响和体重减轻和心血管危险因素的运动:预测和试验的一年结果

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE The long-term impact of intentional weight loss on cardiovascular events remains unknown. We describe 12-month changes in body weight and cardiovascular risk factors in PREvencion con DIeta MEDiterranea (PREDIMED)-Plus, a trial designed to evaluate the long-term effectiveness of an intensive weight loss lifestyle intervention on primary cardiovascular prevention. RESEARCH DESIGN AND METHODS Overweight/obese adults with metabolic syndrome aged 55-75 years (n = 626) were randomized to an intensive weight loss lifestyle intervention based on an energy-restricted Mediterranean diet, physical activity promotion, and behavioral support (IG) or a control group (CG). The primary and secondary outcomes were changes in weight and cardiovascular risk markers, respectively. RESULTS Diet and physical activity changes were in the expected direction, with significant improvements in IG versus CG. After 12 months, IG participants lost an average of 3.2 kg vs. 0.7 kg in the CG (P = 5% occurred in 33.7% of IG participants compared with 11.9% in the CG (P < 0.001). Compared with the CG, cardiovascular risk factors, including waist circumference, fasting glucose, triglycerides, and HDL cholesterol, significantly improved in IG participants (P < 0.002). Reductions in insulin resistance, HbA(1c), and circulating levels of leptin, interleukin-18, and MCP-1 were greater in IG than CG participants (P < 0.05). IG participants with prediabetes/diabetes significantly improved glycemic control and insulin sensitivity, along with triglycerides and HDL cholesterol levels compared with their CG counterparts. CONCLUSIONS PREDIMED-Plus intensive lifestyle intervention for 12 months was effective in decreasing adiposity and improving cardiovascular risk factors in overweight/obese older adults with metabolic syndrome, as well as in individuals with or at risk for diabetes.
机译:目的目的是故意减肥对心血管事件的长期影响仍然未知。我们描述了12个月的体重和心血管危险因素在预防康涅狄格地中海(预先) - 普通的危险因素,旨在评估密集体重损失生活方式干预对初级心血管预防的长期有效性。研究设计和方法超重/肥胖的成人具有55-75岁(N = 626)的代谢综合征(n = 626)是基于能量限制的地中海饮食,身体活动促进和行为支持(IG)或对照组(CG)。主要和二次结果分别是重量和心血管风险标志物的变化。结果饮食和身体活动的变化在预期的方向上,IG与CG的显着改善。 12个月后,IG参与者平均损失3.2千克,CG中的0.7千克(P = 5%在33.7%的IG参与者中发生,而CG中的11.9%(P <0.001)。与CG,心血管相比危险因素,包括腰围,空腹葡萄糖,甘油三酯和HDL胆固醇,IG参与者显着改善(P <0.002)。降低胰岛素抵抗,HBA(1C)和瘦蛋白,白细胞介素-18和MCP的循环水平。 IG比CG参与者更大(P <0.05)。IG与糖尿病患者的参与者显着提高血糖控制和胰岛素敏感性,以及与其CG对应物相比的甘油三酯和HDL胆固醇含量。结论预先加上12个强化生活方式干预几个月有效降低肥胖和改善超重/肥胖老年人的心血管危险因素,其代谢综合征以及患有糖尿病患者的个体。

著录项

  • 来源
    《Diabetes care》 |2019年第5期|共12页
  • 作者单位

    Rovira &

    Virgili Univ Univ Hosp St Joan de Reus Pere Virgili Inst Hlth Res IISPV Dept Biochem &

    Rovira &

    Virgili Univ Univ Hosp St Joan de Reus Pere Virgili Inst Hlth Res IISPV Dept Biochem &

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Rovira &

    Virgili Univ Univ Hosp St Joan de Reus Pere Virgili Inst Hlth Res IISPV Dept Biochem &

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Hosp Clin Univ Endocrinol &

    Nutr Dept Barcelona Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Univ Miguel Hernandez Nutr Epidemiol Unit Alicante Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Epidemiol &

    Salud Publ CIBE Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Epidemiol &

    Salud Publ CIBE Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    UAM CSIC Nutr Genom &

    Epigen Grp Madrid Inst Adv Studies IMDEA Food Inst Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Epidemiol &

    Salud Publ CIBE Madrid Spain;

    Univ Complutense Madrid Inst Invest Sanitaria Hosp Clin San Carlos IdiSSC Fac Med Endocrinol &

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Rovira &

    Virgili Univ Univ Hosp St Joan de Reus Pere Virgili Inst Hlth Res IISPV Dept Biochem &

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Rovira &

    Virgili Univ Univ Hosp St Joan de Reus Pere Virgili Inst Hlth Res IISPV Dept Biochem &

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

    Inst Salud Carlos III Ctr Invest Biomed Red Fisiopatol Obesidad &

    Nutr Madrid Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号